The number of patients treated for hematological malignancies is increasing steadily. To maximize cure rates, aggressive treatments have been introduced, including high-dose chemotherapy, stem cell transplantation, and targeted therapies. As a result, overall and disease-free survival rates have improved substantially, but at the price of life-threatening toxic and infectious complications that chiefly target the lung. This book provides clinicians caring for patients with hematological malignancies with detailed, up-to-date information onall relevant aspects of pulmonary involvement. Individual sections are devoted to epidemiology, diagnostic strategy, lung infections, non-infectious pulmonary involvement, and treatment, including decision making in patients with acute respiratory failure. Each of these sections contains a number of chapters, all written by leading international experts. In addition, the reader’s attention is drawn to important 'pearls' relating to each condition. Detailed, up-to-date information is provided on all relevant aspects of pulmonary involvement in patients with hematological malignancies. Leading experts discuss epidemiology, diagnostic strategy, lung infections, non-infectious pulmonary involvement, and treatment, including decision making in patients with acute respiratory failure. Invaluable 'pearls' relating to each condition are presented. INDICE: Preamble and Introduction.-Epidemiology. Diagnostic Strategy in Hematologic Malignancies Patients. Lung Infections in Patients with Hematologic Malignancies.-Noninfectious Pulmonary Involvement in Patients with HematologicMalignancies. Treatment and Difficult Decisions in Patients with Hematologic Malignancies.-Pearls that You Should be Aware of.-Post Face.
- ISBN: 978-3-642-15741-7
- Editorial: Springer Berlin Heidelberg
- Encuadernacion: Cartoné
- Páginas: 850
- Fecha Publicación: 01/03/2011
- Nº Volúmenes: 1
- Idioma: Inglés